Two Sigma Investments, LP Acer Therapeutics Inc. Transaction History

Two Sigma Investments, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.67 - $3.05 $12,120 - $55,177	18,091 New	18,091 $13,000
Q1 2021 May 17, 2021	SELL	$2.47 - $4.39 $31,793 - $56,508	-12,872 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.34 - $2.99 $30,120 - $38,487	12,872 New	12,872 $34,000
Q1 2020 May 15, 2020	SELL	$1.18 - $5.86 $24,829 - $123,306	-21,042 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$2.85 - $4.2 $39,634 - $58,409	-13,907 Reduced 39.79%	21,042 $84,000
Q3 2019 Nov 14, 2019	BUY	$1.95 - $3.93 $16,910 - $34,080	8,672 Added 33.0%	34,949 $111,000
Q2 2019 Aug 14, 2019	BUY	$3.45 - $26.86 $90,655 - $705,800	26,277 New	26,277 $102,000
Q4 2018 Feb 14, 2019	SELL	$16.55 - $30.22 $258,742 - $472,459	-15,634 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$18.0 - $32.83 $281,412 - $513,264	15,634 New	15,634 $482,000

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.